ETHACRYNATE SODIUM (ethacrynate sodium) by Pfizer is clinical pharmacology pharmacokinetics and metabolism ethacrynate sodium acts on the ascending limb of the loop of henle and on the proximal and distal tubules. Approved for edema, heart failure. First approved in 2015.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Pharmacokinetics and Metabolism Ethacrynate sodium acts on the ascending limb of the loop of Henle and on the proximal and distal tubules. Urinary output is usually dose dependent and related to the magnitude of fluid accumulation. Water and electrolyte excretion may be…
Worked on ETHACRYNATE SODIUM at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.